NextPlat Corp (NASDAQ:NXPL) Short Interest Down 15.4% in September

NextPlat Corp (NASDAQ:NXPLGet Free Report) was the recipient of a significant decrease in short interest in September. As of September 15th, there was short interest totalling 118,300 shares, a decrease of 15.4% from the August 31st total of 139,900 shares. Approximately 1.3% of the shares of the company are sold short. Based on an average trading volume of 120,000 shares, the days-to-cover ratio is presently 1.0 days.

NextPlat Price Performance

Shares of NXPL opened at $1.42 on Monday. The firm has a market capitalization of $26.66 million, a PE ratio of -5.68 and a beta of 0.89. The company’s 50-day moving average is $1.22 and its 200-day moving average is $1.24. NextPlat has a fifty-two week low of $0.99 and a fifty-two week high of $2.68. The company has a debt-to-equity ratio of 0.03, a current ratio of 3.30 and a quick ratio of 2.93.

NextPlat (NASDAQ:NXPLGet Free Report) last released its quarterly earnings results on Wednesday, August 14th. The company reported $0.24 EPS for the quarter. The business had revenue of $16.99 million for the quarter. NextPlat had a negative net margin of 7.59% and a positive return on equity of 29.57%.

NextPlat Company Profile

(Get Free Report)

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.

Featured Articles

Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.